Biobank Data Governance Begins with Specimen Meaning
Holding
A biobank becomes operationally trustworthy when specimen identity, consent, quality, and permitted use remain linked in every downstream system.
Issue
Biobank programs often focus on storage capacity while under-specifying the data controls that make specimens usable. A vial without reliable provenance or use restrictions is not a dependable research asset.
Analysis
The failure mode is semantic separation: consent lives in one system, specimen metadata in another, and assay output in a third with no enforceable relationship between them.
Resolution
The system should bind each specimen and derivative to collection context, consent scope, processing history, quality state, and authorized use. Requests should be checked against those attributes before material or data is released.
Evidence Package
The evidence package should include consent mappings, specimen lineage, freezer and location records, quality assessments, access decisions, transfer logs, and disposition records.
Conclusion
Biobank governance should be implemented as linked identity and authorization controls, not as a folder of policies.